MedTrace Logo

EVPOME Versus AlloDerm in Subjects Reconstructed With Large Defect Mandibular Resection

NCT01834339 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2017-11-22

No results posted yet for this study

Summary

The purpose of this study is to compare the safety and effectiveness of performing oral reconstructive surgeries using either AlloDerm, a product commonly used for this purpose, or AlloDerm that has been overlaid with the subject's oral mucosal cells and developed into a type of graft that is called an ex vivo produced oral mucosal equivalent, EVPOME.

Conditions

  • Mandibular Injuries

Interventions

BIOLOGICAL

AlloDerm

BIOLOGICAL

EVPOME

Sponsors & Collaborators

  • Stephen E. Feinberg

    lead OTHER

Principal Investigators

  • Stephen Feinberg, DDS, MS, PhD · Faculty

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-11-30
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01834339 on ClinicalTrials.gov